Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-848d4c4894-4hhp2 Total loading time: 0 Render date: 2024-05-24T02:04:08.142Z Has data issue: false hasContentIssue false

Chapter 27 - Hyperhidrosis

Published online by Cambridge University Press:  02 November 2023

By
Berthold Rzany  and
Markus K. Naumann
Edited by
Daniel Truong ,
Dirk Dressler ,
Mark Hallett ,
Christopher Zachary  and
Mayank Pathak
Daniel Truong
Affiliation:
University of California, Riverside
Dirk Dressler
Affiliation:
Hannover Medical School
Mark Hallett
Affiliation:
National Institutes of Health (NIH)
Christopher Zachary
Affiliation:
University of California, Irvine
Mayank Pathak
Affiliation:
Truong Neuroscience Institute
Get access

Summary

Hyperhidrosis is excessive sweating, beyond physiological needs. It may be divided into generalized and localized/focal types, and into primary/idiopathic and secondary forms. Primary axillary hyperhidrosis appears to be the most frequent type, followed by palmar hyperhidrosis and other patterns. Hyperhidrosis may negatively affect many fields of daily life to a significant extent, including emotional status, personal hygiene, work and productivity, leisure activities and self-esteem.

When injected intra- or subdermally, botulinum neurotoxin (BoNT) blocks the release of acetylcholine from the sympathetic nerve fibers that stimulate the eccrine sweat glands and causes a localized, long-lasting but reversible abolishment of sweating. This chapter describes in detail the techniques for BoNT injection to treat primary axillary and palmar hyperhidrosis, as well as showing treatment of scalp and segmental hyperhidrosis. Techniques for assessing the degree and distribution of hyperhidrosis, the area to be treated and the degree of benefit are described.

Keywords

Botulinum neurotoxinBoNThyperhydrosispalmar hyperhydrosisaxillary hyperhydrosisonabotulinumtoxinAincobotulinumtoxinAabobotulinumtoxinARoss syndrome
Type
Chapter
Information
Manual of Botulinum Toxin Therapy , pp. 223 - 229
Publisher: Cambridge University Press
Print publication year: 2023

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Anders, D, Moosbauer, S, Naumann, MK, Hamm, H (2008). Craniofacial hyperhidrosis successfully treated with botulinum toxin type A. Eur J Dermatol, 18, 87–8.Google ScholarPubMed
Baumann, L, Slezinger, A, Halem, M et al. (2005). Double-blind, randomized, placebo-controlled pilot study of the safety and efficacy of Myobloc (botulinum toxin type B) for the treatment of palmar hyperhidrosis. Dermatol Surg, 31, 263–70.Google Scholar
Campanati, A, Bernardini, ML, Gesuita, R, Offidani, A (2007). Plantar focal idiopathic hyperhidrosis and botulinum toxin: a pilot study. Eur J Dermatol, 17, 52–4.Google Scholar
Campanati, A, Sandroni, L, Gesuita, R et al. (2011). Treatment of focal idiopathic hyperhidrosis with botulinum toxin type A: clinical predictive factors of relapse-free survival. J Eur Acad Dermatol Venereol, 25, 917–21.CrossRefGoogle ScholarPubMed
Charrow, A, DiFazio, M, Foster, L, Pasquina, PF, Tsao, JW (2008). Intradermal botulinum toxin type A injection effectively reduces residual limb hyperhidrosis in amputees: a case series. Arch Phys Med Rehabil, 89, 1407–9.CrossRefGoogle ScholarPubMed
Davarian, S, Kalantari, KK, Rezasoltani, A, Rahimi, A (2008). Effect and persistency of botulinum toxin iontophoresis in the treatment of palmar hyperhidrosis. Australas J Dermatol, 49, 75–9.Google Scholar
Doft, MA, Hardy, KL, Ascherman, JA (2012). Treatment of hyperhidrosis with botulinum toxin. Aesthet Surg J, 32, 238–44.Google Scholar
Dressler, D (2010). Comparing Botox and Xeomin for axillar hyperhidrosis. J Neural Transm, 117, 317–19.Google Scholar
Dressler, D, Adib Saberi, F, Benecke, R (2002). Botulinum toxin type B for treatment of axillar hyperhidrosis. J Neurol, 249, 1729–32.Google Scholar
Glaser, DA, Coleman, WP III, Fan, LK et al. (2012). A randomized, blinded clinical evaluation of a novel microwave device for treating axillary hyperhidrosis: the dermatologic reduction in underarm perspiration study. Dermatol Surg, 38, 185–91.Google Scholar
Hamm, H, Naumann, MK, Kowalski, JW et al. (2006). Primary focal hyperhidrosis: disease characteristics and functional impairment. Dermatology, 212, 343–53.Google Scholar
Heckmann, M, Ceballos-Baumann, AO, Plewig, G (2001). Botulinum toxin A for axillary hyperhidrosis (excessive sweating). N Engl J Med, 344, 488–93.CrossRefGoogle ScholarPubMed
Hoorens, I, Ongenae, K (2012). Primary focal hyperhidrosis: current treatment options and a step-by-step approach. J Eur Acad Dermatol, Venereol 26, 1–8.CrossRefGoogle Scholar
Hornberger, J, Grimes, K, Naumann, M et al. (2004). Multi-Specialty Working Group on the Recognition, Diagnosis, and Treatment of Primary Focal Hyperhidrosis. Recognition, diagnosis, and treatment of primary focal hyperhidrosis. J Am Acad Dermatol, 51, 274–86.CrossRefGoogle Scholar
Hunt, SV, Malhotra, R (2022). Bacteriostatic preserved saline for pain-free periocular injections: review. Eye (Lond), 36(8), 1546–52.Google Scholar
Kim, WO, Kil, HK, Yoon, KB, Noh, KU (2009). Botulinum toxin: a treatment for compensatory hyperhidrosis in the trunk. Dermatol Surg, 35(5), 833–8.CrossRefGoogle ScholarPubMed
Kinkelin, I, Hund, M, Naumann, M, Hamm, H (2000). Effective treatment of frontal hyperhidrosis with botulinum toxin A. Br J Dermatol, 143, 824–7.Google Scholar
Lee, DG, Kim, JE, Lee, WS et al. (2022) A phase 3, randomized, multi-center clinical trial to evaluate the efficacy and safety of neu-BoNT/A in treatment of primary axillary hyperhidrosis. Aesthetic Plast Surg, 46(3), 1400–6. http://doi.org/10.1007/s00266-021-02715-4Google Scholar
Lowe, NJ, Yamauchi, PS, Lask, GP, Patnaik, R, Iyer, S (2002). Efficacy and safety of botulinum toxin type A in the treatment of palmar hyperhidrosis: a double-blind, randomized, placebo-controlled study. Dermatol Surg, 28, 822–7.Google Scholar
Lowe, NJ, Glaser, DA, Eadie, N et al. (2007). North American Botox in Primary Axillary Hyperhidrosis Clinical Study Group. Botulinum toxin type A in the treatment of primary axillary hyperhidrosis: a 52-week multicenter double-blind, randomized, placebo-controlled study of efficacy and safety. J Am Acad Dermatol, 56, 604–11.Google Scholar
Naumann, MK, Lowe, NJ for the Botox Hyperhidrosis Clinical Study Group (2001). Botulinum toxin type A in treatment of bilateral primary axillary hyperhidrosis: randomised, parallel group, double blind, placebo controlled trial. BMJ, 323, 1–4.CrossRefGoogle ScholarPubMed
Naumann, MK, Hamm, H, Lowe, NJ for the Botox Hyperhidrosis Clinical Study Group (2002). Effect of botulinum toxin type A on quality of life measures in patients with excessive axillary sweating: a randomized controlled trial. Br J Dermatol, 147, 1218–26.CrossRefGoogle ScholarPubMed
Naumann, MK, Lowe, NJ, Kumar, CR, Hamm, H (2003). Botulinum toxin type A is a safe and effective treatment for axillary hyperhidrosis over 16 months: a prospective study. Arch Dermatol, 139, 731–6.Google Scholar
Nestor, MS, Park, H (2014). Safety and Efficacy of Micro-focused Ultrasound Plus Visualization for the Treatment of Axillary Hyperhidrosis. J Clin Aesthet Dermatol., 7, 14-21.Google ScholarPubMed
Saadia, D, Voustianiouk, A, Wang, AK, Kaufmann, H (2001). Botulinum toxin type A in primary palmar hyperhidrosis: randomized, single-blind, two-dose study. Neurology, 57, 2095–9.CrossRefGoogle ScholarPubMed
Simonetta Moreau, M, Cauhepe, C, Magues, JP, Senard, JM (2003). A double-blind, randomized, comparative study of Dysport vs. Botox in primary palmar hyperhidrosis. Br J Dermatol, 149, 1041–5.Google Scholar
Sugimura, H, Spratt, EH, Compeau, CG, Kattail, D, Shargall, Y (2009). Thoracoscopic sympathetic clipping for hyperhidrosis: long-term results and reversibility. J Thorac Cardiovasc Surg. 137(6), 1370-6Google Scholar
Suh, DH, Lee, SJ, Kim, K et al. (2014) Transient median and ulnar neuropathy associated with a microwave device for treating axillary hyperhidrosis. Dermatol Surg, 40, 482-5.CrossRefGoogle ScholarPubMed
Strutton, DR, Kowalski, JW, Glaser, DA, Stang, PE (2004). US prevalence of hyperhidrosis and impact on individuals with axillary hyperhidrosis: results from a national survey. J Am Acad Dermatol, 51, 241–8.Google Scholar
Trindade de Almeida, AR, Secco, LC, Carruthers, A (2011). Handling botulinum toxins: an updated literature review. Dermatol Surg, 37, 1553–65.Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×